Monitoring gene expression in muscle tissue of macaca fascicularis under the influence of testosterone and SARM

Hormone Molecular Biology and Clinical Investigation

Volumn 1, Issue 2, 2010, Pages 73-79

  Reiter, Martina ^a   Tichopad, Ales ^a   Riedmaier, Irmgard ^a   Pfaffl, Michael W ^a   Meyer, Heinrich H D ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

candidate gene approach; expression profiling; qRT PCR; selective androgen receptor modulator; testosterone

Indexed keywords

BIOLOGICAL MARKER; LGD 2941; MUSCLE PROTEIN; SELECTIVE ANDROGEN RECEPTOR MODULATOR; TESTOSTERONE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CONTROLLED STUDY; ENERGY METABOLISM; GENE EXPRESSION; MACACA FASCICULARIS; MALE; MUSCLE BIOPSY; MUSCLE TISSUE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; QUADRICEPS FEMORIS MUSCLE; SATELLITE CELL; TRICEPS BRACHII MUSCLE;

EID: 84859880136     PISSN: 18681883     EISSN: 18681891     Source Type: Journal    
DOI: 10.1515/HMBCI.2010.007     Document Type: Article

References (29)

1. Bross R., Storer T., Bashin S. Aging and muscle loss. Trends Endocrinol Metab 1999;10:194-8.
2. Muller M., Grobbee DE., Thijssen JH. Sex hormones and male health: effects on components of the frailty syndrome. Trends Endocrinol Metab 2003;14:289-96.
3. Van den Beld A., Huhtaniemi IT., Pettersson KS., Pols HA., Grobbee DE., de Jong FH., Lamberts SW. Luteinizing hormone and different genetic variants, as indicators of frailty in healthy elderly men. J Clin Endocrinol Metab 1998;84:1334-9.
4. Yialamas MA., Hayes FJ. Androgens and the ageing male and female. Best Practice Res: Clin Endocrinol Metab 2003;17: 223-6.
5. D'Antona G., Pellegrino MA., Broca L., Adami R., Rossi R., Moro G., Miotti D., Canepari M., Bottinelli R. The effect of ageing and immobilization on structure and function of human skeletal muscle fibres. J Physiol 2003;552:499-511.
6. D'Antona G., Lanfranconi F., Pellegrino MA., Broca L., Adami R., Rossi R., Moro G., Miotti D., Canepari M., Bottinelli R. Skel-etal muscle hypertrophy and structure and function of skeletal muscle fibres in male body builders. J Physiol 2006;570: 611-27.
7. Frontera WR., Hughes VA., Fielding RA. Aging of skeletal muscle: a 12-yr longitudinal study. J Appl Physiol 2000;88:1321-6.
8. Bhasin S., Bagatell CJ., Bremner WJ., Plymate SR., Tenover JL., Korenman SG., Nieschlag E. Therapeutic perspective: issues in testosterone replacement in older men. J Clin Endocrinol Metab 1998;83:3435-6.
9. Bartoli M., Richard I. Calpains in muscle wasting. Int J Biochem Cell Biol 2005;37:2115-33.
10. Stockholm D., Herasse M., Marchand S., Praud C., Roudaut C., Richard I., Sebille A., Beckmann JS. Calpain 3 mRNA expression in mice after denervation and during muscle regeneration. Am J Physiol Cell Physiol 2001;280:C1561-9.
11. Welle S., Bhatt K., Thornton C. Polyadenylated RNA., actin mRNA, and myosin heavy chain mRNA in young and old human skeletal muscle. Am J Physiol 1996;270:E224-9.
12. Davis S. Androgen replacement in women: a commentary. J Clin Endocrinol Metab 1999;84:1886-91.
13. Davis SR. The therapeutic use of androgens in women. J Steroid Biochem Mol Biol 1999;69:177-84.
14. Deschenes MR. Effects of aging on muscle fibre type size. Sports Med 2004;34:809-24.
15. Doherty TJ. Invited review: aging and sarcopenia. J Appl Physiol 2003;95:1717-27.
16. Lopez FJ. New approaches to the treatment of osteoporosis. Curr Opin Chem Biol 2000;4:383-93.
17. Chen F., Rodan GA., Schmidt A. Development of selective androgen receptor modulators and their therapeutic applications. Zhonghua Nan Ke Xue 2002;8:162-8.
18. Negro-Vilar A. Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium. J Clin Endocrinol Metab 1999;84:3459-62.
19. Rosen J., Negro-Vilar A. Novel., non-steroidal., selective andro-gen receptor modulators (SARM) with anabolic activity in bone and muscle and improved safety profile. J Musculoskelet Neuron Interact 2002;2:222-4.
20. Yin D., Gao W., Kearbey JD. Pharmakodynamics of selective androgen receptor modulators. J Pharmacol Exp Ther 2003;304: 1334-40.
21. Fleige S., Pfaffl MW. RNA integrity and the effect on the realtime qRT-PCR performance. Mol Aspects Med 2006;27:126-39.
22. Schroeder A., Mueller O., Stocker S., Salowsky R., Leiber M., Gassmann M., Lightfood S., Menzel W., Granzow M., Ragg T. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 2006;31:3.
23. Baxter RC. Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 2000;278:E967-76.
24. Florini JR., Ewton DZ., Coolican SA. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev 1996;17:481-517.
25. Jones JI., Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3-34.
26. Pell JM., Bates PC. Differential actions of growth hormone and insulin-like growth factor I on tissue protein metabolism in dwarf mice. Endocrinology 1992;130:1942-50.
27. Bechet D., Tassa A., Taillandier D., Comaret L., Attaix D. Lyso-somal proteolysis in skeletal muscle. Int J Biochem Cell Biol 2005;37:2098-114.
28. Dargelos E., Moyen C., Dedieu S. Development of an inducible system to assess p94 (CAPN3) function in cultured muscle cells. J Biotechnol 2002;96:271-9
29. Stockholm D., Herasse M., Marchand S., Praud C., Roudaut C., Richard I., Sebille A., Beckmann JS. Calpain 3 mRNA expression in mice after denervation and during muscle regeneration. Am J Physiol Cell Physiol 2001;280:C1561-9.